Updated April 14, 2025:
Research Overview
Soybean production in the North Central US is increasingly threatened by pathogen pressures which can be exacerbated by shifting environmental conditions, including milder winters and warmer summer months. Diseases such as frogeye leaf spot and white mold are now common throughout much of the region, alongside emerging threats like red crown rot in the southern portion of the North Central region and the development of sudden death syndrome in the northern tier of the North Central region. In response, farmers have needed to adopt intensive disease management practices involving increased use of seed treatments with multiple modes of action, consistent and often multiple fungicide applications, and shifts in maturity groups. These practices, while potentially effective, raise concerns regarding higher production costs and the risk of developing fungicide-resistant pathogens. Therefore, there is a need to evaluate and optimize both high-intensity and low-intensity management practices to identify effective and economically viable approaches to disease control.
The surge in biological control products, including beneficial bacteria and fungi, presents promising sustainable alternatives to chemical controls. However, their practical efficacy and economic viability in soybean production remain uncertain due to a lack of standardized field data. Recent localized surveys from the University of Nebraska-Lincoln indicate significant gaps in current disease management practices, such as excessive fungicide use and limited understanding of fungicide modes of action. To address these challenges, this research proposes conducting multi-site trials to assess the effectiveness and return on investment (ROI) of varying fungicide trials. Further, economic analyses using historical and current trial data will further refine our understanding of conditions under which specific strategies result in the greatest economic returns.
Additionally, this project will conduct a survey of soybean farmers across the North Central region to identify and address knowledge gaps, management practices, and decision-making drivers. Insights gained from this survey will guide targeted Extension outreach and inform the development of effective educational materials and interactive decision-support tools. Further, tools from the previously discussed economic analyses will be incorporated into a new decision support system, which will assist farmers in making informed and economically beneficial decisions on disease management practices. Ultimately, this multi-state project aims to improve the productivity and profitability of soybean farming within the North Central region.
Objectives
Objective 1: Integrated disease management strategies, fungicide efficacy, and economic viability of these strategies will be evaluated across the North Central region.
Objective 1a: High-Intensity vs. Low-Intensity Uniform Disease Management Trials
Objective 1b: Uniform Fungicide Trials for Foliar Soybean Diseases
Objective 1c: Economic Analysis of Uniform Fungicide Trials
Objective 2: The efficacy of commercial biological control products will be evaluated for their reduction of soybean disease development.
Objective 2a: Biological Control Products for White Mold
Objectives 2b and 2c: Biological Control Seed Treatment Trials for Pythium/Phytophthora and Sudden Death Syndrome
Objective 3: A survey will be distributed to farmers across the North Central region to better understand the current farmer knowledge of soybean diseases and what is driving their disease management decisions.
Objective 4: Develop Extension material and interactive disease management decision tools
Objective 4a: Development of Extension Material
Objective 4b: Develop New Management Decision Tools
Completed Work and Objective Progress
Progress on the pathology led project has been moving forward steadily. At the beginning of the project in October of 2024, all seven PIs/co-PIs met in Madison, Wisconsin to plan for the next three years of the project. At this meeting, each co-PI presented the objective that they will be leading and their plans for completing each objective. Updates on each objective are listed below.
Objective 1.
Objective 1a. Field trials examining varying levels of soybean disease management are being led by Dr. Dylan Mangel from the University of Nebraska-Lincoln. Within these trials, there will be 8 treatments examined which will include the following. These will be focusing on combinations of seed treatment with foliar fungicide applications. Each combination of these will be explored exemplifying high intensity in management practices to low intensity.
Treatment Number Seed Treatment Foliar Application 1 Foliar Application 2
1 Non-treated - -
2 CruiserMaxx & Saltro Delaro Complete 8 floz/ac @ R1 Delaro Complete 8 floz/ac @ R3
3 CruiserMaxx & Saltro - Delaro Complete 8 floz/ac @ R3
4 CruiserMaxx & Saltro - -
5 - Delaro Complete 8 floz/ac @ R1 Delaro Complete 8 floz/ac @ R3
6 - - Delaro Complete 8 floz/ac @ R3
7 CruiserMaxx & Saltro Delaro Complete 8 floz/ac following Frogspotter -
8 - Delaro Complete 8 floz/ac following Frogspotter -
For this objective, 7 site-years will be conducted with one location in each of the seven representative states. Seed of these varieties have been sourced and are currently being treated at the University of Nebraska-Lincoln by the Mangel team. The seed will be distributed to each university within the next few weeks. Progress is moving smoothly with no barriers at this time.
Objective 1b. Field trials examining multiple soybean foliar fungicide programs will be led by Dr. Darcy Telenko of Purdue University. The treatments being tested are listed here.
Treatment Number Fungicide Program
1 Non-treated Control
2 Delaro Complete 8 floz/ac @ R3
3 Delaro Complete 8 floz/ac @ R5
4 Delaro Complete 8 floz/ac @ R3 & R5
5 Adastrio 8 floz/ac @ R3
6 Badge SC 1.5 pt/ac @ R3
7 Affiance 14 floz/ac @ R3
8 Generic Quilt (Tigris Azoxyprop) 12 floz/ac @ R3
9 Generic Quilt (Tigris Azoxyprop) 12 floz/ac @ R5
10 Viatude 16 floz/ac @ R3
These treatments will be examining multiple commercially available products that farmers are using across the region. Further, we are examining the use of generic products as well which would offer a more cost-effective option for farmers, if efficacy is not reduced. Lastly, we are examining the application of products at the R5 growth stage due to the lack of information available on this timing. This lack of information came to be known after Hurricane Helene moved through parts of Indiana and Ohio in 2024, leaving many soybean acres affected by fungal infections. As a result, it was questioned if later fungicide applications could have mediated these infections, and therefore we plan to evaluate these timings to acquire data for these later growth stages.
For this objective,10 site years will be conducted across the seven states. Currently, protocols have been distributed to all co-PIs, seed is being sourced, and trials will be planted shortly. Each PI is also working on sourcing fungicides from each company as well for evaluation. Progress is moving smoothly with no barriers at this time.
Objective 1c. A meta-analysis of historical white mold fungicide trials is currently underway and led by Dr. Damon Smith out of the University of Wisconsin-Madison. A dataset has been created and finalized with trial data dating from 2017-2024 across seven states. This dataset includes data looking at various commercially available fungicide products with varying application timings. To assist in the conducting of this analysis the Data Science Institute at the University of Wisconsin-Madison has been brought in for their expertise in examining the primary ANOVA tables from data of each individual field trial. From these ANOVA tables, we are currently working on conducting a weighted network meta-analysis from these results. It is expected that much progress will be made in the next 6 months of this project. Progress has been moving rapidly for this sub-objective which is ahead of schedule. We do not expect any barriers for this project in the near future.
Objective 2.
Objective 2a. White mold is caused by the fungal pathogen Sclerotinia sclerotiorum which forms long-term survival structures called sclerotia which survive in field soil. In this objective, management by commercial biological control agents will be investigated by field trials examining the application of products focused on the degradation of these sclerotia in the soil. This objective is co-led by Drs. Darcy Telenko, Damon Smith, and Wade Webster. Currently, sclerotia from S. sclerotiorum are being grown under laboratory conditions, and then these sclerotia will either be buried or placed on the surface of the soil within small mesh sample bags. These sclerotia will then have these biological products applied over the top and left fallow for an entire season. These trials will be conducted by using either Contans (active agent: Coniothyrium minitans), Theia (active agent: Bacillus subtilis strain AFS032321), and RootShield Plus (active agents: Trichoderma harzianum and T. virens). All of these species are biological agents with mycoparastism which are known to degrade fungal organisms such as S. sclerotiorum. At four time-points over 12 months these sclerotia will be recovered from the field and evaluated for degradation. To evaluate this degradation, the sclerotia will be plated onto potato dextrose agar growth media and observations will be made if fungal growth appears out of the sclerotia. It is expected that the biological control products will have varying degrees of degradation across the North Central region. We will also be collecting soil samples at the establishment of each trial to examine the soil texture and the levels of biological activity by using Solvita tests. This data will allow for us to better understand which soil conditions are more favorable for sclerotial degradation compared to others. These trials will be conducted across seven site years in the region during 2025.
Objective 2b. The evaluation of biological seed treatment products for the control of oomycete pathogens is being led by Dr. Wade Webster. A total of four biological products alongside two controls have been identified that are of interest to the group for control of these pathogens. These trials will be inoculated with either Pythium or Phytophthora for disease reduction or will be planted into fields with a history of soybean seedling diseases. The seed treatments in this study will include the following.
Treatment Number Fungicide Program
1 Non-treated Control
2 Base (CruiserMaxx) @1.38 floz/140,000 seeds
3 Base + RootShield Plus @ 2 lbs/140,000 seeds
4 Base + Terrasym 401 @ 0.125 oz per 140,000 seeds
5 RootShield Plus @ 2 lbs/140,000 seeds
6 Terrasym 401 @ 0.125 oz per 140,000 seeds
Further, we have added an additional component to this objective in an attempt to standardize vigor ratings. We have coordinated with Dr. Mark Licht from Iowa State University to help perform standardized drone imagery across these trials at the V2 growth stage in addition to on-ground validation of seedling height, biomass, and stand counts. This work will lead to the development of a standardized method of determining and measuring plant vigor for improved understanding of how these type of products impact overall soybean health. These trials will be conducted across 11 site years in the North Central region. Seed is being treated at Iowa State University and will be distributed to each state in early April for planting in the spring. Progress is moving smoothly with no barriers at this time.
Objective 2c. Biological control of SDS by seed treatments is being led by Dr. Daren Mueller at Iowa State University. A total of 6 seed treatments have been identified alongside controls. Trials will be conducted in fields naturally infested with SDS. These trials will be conducted across 8 site-years in 2025. Seed is being treated at Iowa State and will be distributed to each state in early April.
Treatment Number Fungicide Program
1 Non-treated Control
2 Base (CruiserMaxx) @1.38 floz/140,000 seeds
3 Base + CeraMax + Germate Plus
4 Base + Avodigen + Adaplan + Ethos Elite
5 Base + TBZ + Headsup + Biost 2nd Gen + Ascribe SAR
6 Base + RootShield Plus
7 Base + ILEVO
Objective 3. Farmer Survey
Dr. Horacio Lopez-Nicora has led discussions with a survey consultant company, called PRIME46, to initiate the development of this survey in the second quarter of 2025 to capture soybean farmers’ level of understanding of soybean disease impact and management decisions. The survey tool, including questionnaires, a list of participants, and inclusion-exclusion criteria, is currently under development. We expect the survey to be completed by the third quarter of 2025. Establishing this baseline will aid researchers and stakeholders in identifying critical knowledge gaps, ultimately enhancing the protection of soybean health. Progress of this objective is moving along smoothly, and we do not see any major barriers at this time.
Objective 4. The development of new Extension material has been progressing nicely. Through the Crop Protection Network, our group has been involved in the updating of publications as of the spring of 2025 including the ‘Fungicide Efficacy for Control of Soybean Foliar Diseases’, ‘Fungicide Efficacy for Control of Soybean Seedling Diseases’, and ‘Soybean Disease Loss Estimates from the United States and Ontario, Canada – 2024’. Further, new publications involving our team included the ‘Scouting for Soybean Stem Diseases’, ‘Monitoring for resistance to the SDHI fungicide seed treatments ILEVO (fluopyram) and Saltro (pydiflumetofen) for soybean sudden death syndrome (SDS ) management’. Also, a new CPN TV video was recently released titled ‘White Mold: Insights and Updates for 2025’ which was created by Drs. Chilvers, Smith, and Webster. During the year of 2024, a total of 67,892 page views were recorded for all soybean content, which is up from 27,000 in 2022 and 41,000 in 2023. Progress is moving smoothly with the development of new Extension material for the benefit of North Central soybean farmers and more content will be developed in the coming years of this project.
View uploaded report 